Keyphrases
Hospitalized Patients
100%
Aminocaproic Acid
100%
Patients with Hematological Malignancies
100%
Bleeding
75%
Refractory Thrombocytopenia
37%
Hematological Malignancies
25%
Trial Protocol
12%
Malignancy
12%
Adult Patients
12%
Adjunct Therapy
12%
Retrospective Review
12%
Blood Loss
12%
Oral Formulation
12%
Deep Vein Thrombosis
12%
Transfusion Requirements
12%
Antifibrinolytics
12%
Intravenous Formulation
12%
Duration of Use
12%
Thrombotic Events
12%
Surgical Environment
12%
Formalized Protocol
12%
Indications for Use
12%
Pharmacology, Toxicology and Pharmaceutical Science
Hematologic Malignancy
100%
Aminocaproic Acid
100%
Bleeding
62%
Refractory Thrombocytopenia
37%
Observational Study
12%
Antifibrinolytic Agent
12%
Deep Vein Thrombosis
12%